Forbes Medi-Tech: Progress with Food Manufacturer

Business Wire, Oct 20, 1997

VANCOUVER, British Columbia--(BUSINESS WIRE)--Oct. 20, 1997-- Forbes Medi-Tech Inc. (VSE:FMI. ) Forbes Medi-Tech Inc. (VSE:FMI) (the "Company") is pleased to announce that pursuant to the Letter Agreement signed with a major food manufacturer ("Manufacturer") as reported in the company's news release of March 18, the company presented the results of its "Food/Phytrol" trial on September 11 to the Manufacturer for evaluation and interest.

The company is pleased to report that the Management of the Manufacturer has found the results of the trial favorable and of interest and has notified the company that it wishes to proceed to negotiate an appropriate licensing Agreement with the Company.

Forbes Medi-Tech Inc. is a bio-technology company dedicated to research, development and commercialization of valuable pharmaceuticals derived from forest industry by-products. Forbes is devoting its efforts to researching forest-derived plant sterols for use as cholesterol lowering agents as well as the production and commercialization of Androstenedione, a key material used in the manufacture of various pharmaceutical steroid drugs and other "higher value" steroid products.

For more information, please contact Don Lay, Investor Relations, at 604/681-8976 or by e-mail at ir@forbesmedi-tech.com . Our website can be visited at http://www.forbesmedi-tech.com .

On Behalf of the Board of Directors of Forbes Medi-Tech Inc.

Tazdin Esmail, President -0-

NOTE TO EDITORS:

The Vancouver Stock Exchange has not reviewed and does

not accept responsibility for the adequacy or accuracy of the

content of this News Release. The statements made in this News

Release may contain certain forward-looking statements. Actual

events or results may differ from the Company's expectations.

Certain risk factors may also affect the actual results achieved

by the Company. Exemption from registration pursuant to Rule

12(g)3-2(b) 82-3139.

CONTACT: Forbes Medi-Tech Inc.

Don Lay, 604/681-8976

E-mail: ir@forbesmedi-tech.com

Website: http://www.forbesmedi-tech.com